Delivery Order SPE2DB22D1017-SPE2DB24FE7YH
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,074.58 firm-fixed-price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication, with a completion date of January 31, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,939.93 fixed-price delivery order is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,674.74 firm fixed-price delivery order is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. The award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,239.97 firm fixed-price delivery order is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of February 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,037.76 firm-fixed-price delivery order covers the supply of Micardis HCT 40-12.5 mg tablets, a cardiovascular medication, with a completion date of September 23, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,528.27 firm fixed-price delivery order is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,063.60 firm fixed-price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication. The award is not designated as a set-aside contract. The contract has an ultimate completion date of September 18, 2024 and is associated with a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,738.40 firm fixed-price delivery order is for the supply of MICARDIS HCT 40-12.5 MG TABLET medication to support the agency's medical product needs. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC enables the agency to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,556.64 firm fixed-price delivery order is for the supply of Micardis HCT 80-25 mg tablets, a cardiovascular medication, with an ultimate completion date of January 18, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,126.56 firm-fixed-price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a prescription medication. The contract has an ultimate completion date of November 13, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FE7YHDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,816.00, is a Firm Fixed Price Delivery Order for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/3/23 |